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The goal of this study was to measure the eﬀective refractory period (ERP), the conduction
velocity (CV) and the wavelength (WL) after cardioversion in patients with persistent atrial
ﬁbrillation (AF) and to determine the eﬀects of the adenosine triphosphate sensitive potassium
channel (KATP) opening agent, nicorandil, on those parameters in patients with persistent AF.
METHODS: Patients with AF underwent elective cardioversion followed by measurement
of ERP and CV before and after administration of nicorandil. Parameters were measured
again one week later, and the ERP and the CV was used to calculate WL.
RESULTS: ERP was signiﬁcantly shorter immediately after termination of AF than at the
1-week time point (193.4 vs. 228.7msec p < 0:01). While there was no signiﬁcant diﬀerence
in ERP immediately after termination of AF when comparing measurements taken before and
after the administration of nicorandil, ERP at the 1-week time point was shorter after
nicorandil administration than before nicorandil administration (193.4 vs. 191.4msec, n.s.;
228.7 vs. 217.2msec, p < 0:01). Further, WL was higher at the 1-week time point after
nicorandil administration than before nicorandil administration.
CONCLUSIONS: These data indicate that the electrical remodeling that occurs after
cardioversion is at least partially mediated by changes in KATP channel behavior. Further, the
electrophysiologic properties, that is, nicorandil prolonging the WL, may be of beneﬁt in
reducing the recurrence rate of AF.
(J Arrhythmia 2005; 21: 371–377)
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Introduction
The adenosine triphosphate (ATP)-sensitive po-
tassium channel (IKATP) is activated by low intra-
cellular concentrations of ATP and acts to shorten
action potential duration (APD).1,2) Nicorandil, a
speciﬁc agonist of IKATP channel, decreases the
eﬀective refractory period (ERP) under hypoxic or
ischemic conditions in ventricular muscle cells, but
the eﬀect of nicorandil in the atria following atrial
ﬁbrillation (AF) remains unclear.
In 1995, Alessie et al. described a goat model of
electrical remodeling induced by high-frequency
atrial stimulation.3,4) Speciﬁcally, continued high-
frequency atrial stimulation induced AF, and the
duration was extended in proportion to the length of
the stimulation period. Further, the presence of the
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AF itself contributed to its persistence. These
experimental studies showed that intracellular cal-
cium overload and shortening the atrial ERP were
important factors contributing to the persistence of
AF.4–6) Other studies demonstrated that the levels of
Kir6.2 mRNA, which encodes for a portion of the
IKATP protein, was decreased in patients with
paroxysmal AF7) and that the IKATP current density
was down-regulated in patients with chronic AF.8)
However, the precise role of IKATP in electrical
remodeling remains unclear.
Maintenance of AF is dependent on the presence
of simultaneous reentrant waves. Animal experi-
ments and computer simulations indicate that AF is
maintained by multiple independent wavelets that
irregularly activate atrial cells at very high rates.9–12)
The minimal size of a reentrant wave is related to the
wavelength (WL), which is deﬁned as the product of
the local refractory period and the local conduction
velocity (CV). Rapid atrial activation reduces CV13)
and increases WL thereby promoting development or
maintenance of AF. However, IKATP channel acti-
vation reduces rest potential and may increase CV
and reduce WL, thereby decreasing the vulnerability
to AF.
Therefore, the goal of this study was to measure
the ERP, CV, and WL after cardioversion and to
determine the eﬀects of nicorandil on WL in patients
with persistent AF.
Methods
Subjects
The patient population consisted of one female
and eleven males (mean age, 58:9 12:2 years;
range, 29 to 72 years). Eight of the 12 patients had
AF (AF group) that had persisted for at least 30 days
(mean duration, 94:9 81:1 days; range, 30 to 279
days; mean age, 60:6 8:1 years), while the other
four patients (control group) did not experience any
episodes of AF (mean age, 55:5 19:2 years). The
mean left atrial diameter (LAD), as determined by
echocardiography, was 39:9 5:8mm in all patients
and was 41:8 5:6 and 36:2 4:6mm in the AF
and control subgroups, respectively (p < 0:1). Co-
morbid conditions included hypertension (n ¼ 4)
and ischemic heart disease (n ¼ 1), and there was no
signiﬁcant diﬀerence in age, gender or comorbid
conditions when comparing the two groups of
patients. All patients were classiﬁed as New York
Heart Association functional class I or II, with no
clinical or instrumental signs of cardiac failure.
(Tables 1 and 2)
The duration of AF before participation in the
current study was determined by regular electro-
cardiography (ECG) and ambulatory Holter ECG
monitoring. All patients remained hospitalized dur-
ing the study. After cardioversion, patients were
monitored by continuous ECG to detect any recur-
rence of atrial ﬁbrillation.
Written informed consent was obtained from all
patients, and the Showa University School of
Medicine approved all protocols.
Electrophysiological Study
Electrophysiological studies (EPS) were per-
formed immediately after cardioversion (Day 1)
and seven days later (Day 7). Cardioversion was
performed on the body surface following intravenous
anesthesia with thiopental and diazepam. Two
catheters were inserted via the femoral vein and
used for EPS studies: a basket-type catheter (EPT
Table 1
All patients
(n ¼ 12)
AF Group
(n ¼ 8)
Control Group
(n ¼ 4) p value
Gender (M/F) 11/1 8/0 3/1 n.s.
Age (years) 58:9 12:2 60:6 8:1 55:5 19:2 n.s.
AF duration (days) — 94:9 81:1 — —
LAD (mm) 39:9 5:78 41:8 5:6 36:2 4:6 <0:1
EF (%) 63:1 7:4 60:4 7:2 68:5 4:2 n.s.
Heart disease (n)
Hypertensive 4 3 1
Ischemic 1 1 0
Lone AF 7 4 3
Data are presented at the mean value  SD or number of patients. AF = atrial ﬁbrillation;
F = female; M = male; EF = left ventricular ejection fraction; LAD = left atrial diametter. A
total of twelve patients, consisting of 11 men and one woman, with a mean age of 58.9 years and a
range of 29 to 73 years were studied. Mean duration of AF was 94.9 days, with a range of 30 to 279
days. Left atrial diameter was 39.9mm, as measured by ultrasound.
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Corp.; 64 electrodes, 32 pairs of bipolar leads; 48 or
60mm diameter based on echocardiographic meas-
urements of the LAD) placed in the right atrium, and
a standard 8-pole electrode catheter for measurement
of the electrical potential of the bundle of His. The
48 and 60mm basket catheters possessed eight
splines, containing eight electrodes with 5 and
4mm inter-electrode distances, respectively. Surface
ECG and endocardial signals, acquired by bipolar
leads, were monitored continuously and stored on a
computer-based digital ampliﬁer/recorder system
(CardioLab, Pruka Engineering Inc., Houston,
TX, USA) on optical disks for oﬄine analysis.
Intracardiac electrograms were ﬁltered from 30 to
500Hz and measured using computer-assisted cali-
pers at a sweep speed of 400mm/sec.
ERP measurements
ERP was measured using 32 pairs of bipolar leads
within the basket catheter that was located in the
right atrium. In all, ERP was measured at 802 points
in the right atrium immediately and one week after
cardioversion. ERP was determined by the longest
coupling interval in which an atrial premature
stimulus was not captured after a seven-beat basic
stimulation with 400 and 600msec basic cycles.
The pacing voltage (10 volts) was determined
from the results of our previous study in which the
diastolic threshold was between 5 and 7 volts using
the basket catheter under the same conditions used in
the current study.
Administration of nicorandil
Nicorandil infusion was performed as described
previously.14) Brieﬂy, 12 milligrams (mg) of nicor-
andil was administered intravenously after baseline
ERP measurements. ERP was measured again within
15 minutes after nicorandil infusion (Day 1 with
nicorandil). The same protocol was repeated one
week after AF termination (Day 7 with nicorandil)
(Figure 1).
Conduction velocity analysis
The distal bipolar (1–2) of each spline of the
basket catheter was paced, and the activation time
from the distal (3–4) to the proximal bipolar (7–8)
was measured. The conduction velocity was calcu-
lated as the activation time divided by the distance
from the distal (3–4) to the proximal bipolar (7–8).
Conduction time was measured at cycle lengths of
Table 2 Clinical and echocardiographic characteristics of patients.
Pt. No. Age Gender AF duration
(days)
LAD
(mm)
EF
(%)
Anti-arrhythmic
drug OHD
No. 1 66 M 113 45.6 69.0 Bepridil IHD
No. 2 53 M 30 32.3 65.0 none HT
No. 3 64 M 39 42.2 52.0 Cibenzoline —
No. 4 71 M 279 42.5 63.0 Bepridil —
No. 5 59 M 60 33.9 51.0 none —
No. 6 68 M 66 47.0 55.0 Cibenzoline —
No. 7 47 M 120 44.6 69.0 none HT
No. 8 57 M 52 46.0 59.0 Cibenzoline HT
No. 9 67 F — 31.0 73.0 Verapamil —
No. 10 54 M — 37.2 63.0 none —
No. 11 29 M — 34.6 70.0 none —
No. 12 72 M — 42.0 68.0 Verapamil HT
Subjects consisted of 12 patients with atrial ﬁbrillation for at least 30 days who subsequently underwent elective
cardioversion. EPS had been performed immediately after AF converted to sinus rhythm. AF = atrial ﬁbrillation;
F = female; M = male; EF = left ventricular ejection fraction; LAD = left atrial diametter; OHD = organic heart
disease, IHD = iscemic heart desease, HT = hyper tension.
Defibrillation
Immediately
1 week
Time
Measure ERP          
Nicorandil i.v.
Measure ERP again 
Time course of current  study.
Measure ERP          
Nicorandil i.v.
Measure ERP again 
Day 1
Day 1 with
nicorandil
Day 7
Day 7 with
nicorandil
Figure 1 Time course of electrophysiologic (EPS) measure-
ments. EPS measurements were obtained immediately after
cardioversion (Day 1) and before and after administration of
nicorandil (Day 1 with nicorandil). One week later, measure-
ments were repeated using the same protocol (Day 7, and Day
7 with nicorandil).
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600msec after stable capture for at least three
seconds.
Statistical Analysis
Data are presented as mean SD. Diﬀerences in
continuous variables were analyzed by the Wilcoxon
Signed Rank Test or the Mann-Whitney U Test when
independent. Atrial wavelength was deﬁned as the
distance traveled by the atrial impulse during the
atrial eﬀective refractory period as follows: wave-
length = ERP  conduction velocity.15) Diﬀerences
were considered signiﬁcant at P < 0:05, and ten-
dency at P < 0:1.
Results
1. Atrial refractoriness
Figure 2 shows the results of the electrophysio-
logical studies performed immediately after and
seven days after cardioversion. The average ERP
values on days 1 and 7 in the AF group were 193:4
21:6msec (172.5–238.9msec) and 228:7 33:2
msec (184.5–282.5msec), respectively, and the
average ERP in the control group was 213:2
19:1msec (196.1–237.1msec). The ERP value was
signiﬁcantly shorter immediately after cardioversion
than on day 7 (p < 0:01). While the ERP on day 7
tended to be longer in the AF group when compared
to the control group, this diﬀerence did not reach the
level of statistical signiﬁcance (Figure 2, left panel).
The ERP values immediately after cardioversion
were similar when comparing values obtained before
and after nicorandil administration (193:4 21:6
msec; range, 172.5–238.9msec vs. 191:4 20:7
msec; range, 171.3–232.3msec). However, the ERP
values obtained one week after cardioversion were
lower in the AF group after administration of
nicorandil (217:2 26:8msec; range, 180.9–264.1
msec) than before administration of nicorandil
(228:7 33:2msec; range, 184.5–282.5msec) (p <
0:01). Further, ERP was lower in the control group
after administration of nicorandil than before admin-
istration of nicorandil, but this diﬀerence did not
reach the level of statistical signiﬁcance (200:1
17:1msec; range, 182.9–217.1msec vs. 213:2 9:1
msec; range, 196.1–237.1msec, n.s.). The response
to nicorandil decreased immediately after cardiover-
sion but recovered after one week (Figure 2, right
panel).
2. Conduction velocity
Conduction velocity was relatively slower in the
AF group immediately after cardioversion when
compared with conduction velocity in the control
group (1:12 0:09 vs. 1:43 0:36m/sec; p < 0:1),
but there was no signiﬁcant diﬀerence in conduction
velocity when comparing values obtained immedi-
ately after cardioversion and those obtained one
week later in the AF group. Conduction velocity
signiﬁcantly increased after nicorandil administra-
tion immediately after and one week after cardio-
version in the AF group (1:12 0:09 vs. 1:26
0:12m/sec, p < 0:05, 1:08 0:10 vs. 1:19 0:12
m/sec p < 0:05, respectively) (Figure 3).
3. Wavelength
WL was relatively shorter immediately after
cardioversion in the AF group when compared with
the control group (216:4 31:8 vs. 309:0 101:8
mm; p < 0:1), and WL was longer seven days after
cardioversion when compared to immediately after
cardioversion in the AF group (216:4 31:8 vs.
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Figure 2 ERP; time course and eﬀect of nicorandil.
Left panel: the mean eﬀective refractory period (ERP) immediately after cardioversion (Day 1) was 193.4msec, which was
signiﬁcantly shorter than the mean ERP seven days after cardioversion (Day 7), which was 228.7msec (p < 0:01).
Right panel: Nicorandil had no eﬀect on ERP immediately after cardioversion (Day 1, and Day 1 with nicorandil: 191.4 vs.
193.4msec; N.S.) but did shorten ERP seven days after cardioversion (Day 7, and Day 7 with nicorandil: 228.7 vs. 217.2msec;
p < 0:01).
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251:3 45:0mm; p < 0:05). Nicorandil administra-
tion increased WL immediately after cardioversion
(216:4 31:8 to 240:6 34:8mm; p < 0:05) and
seven days after cardioversion (251:3 45:0 to
262:5 45:2mm; p < 0:05) (Figure 4). The WL
was shorter immediately after cardioversion in the
AF group than in the control group, and this
diﬀerence persisted at the 7-day time point.
Discussion
Major Findings
The present study demonstrated that the ERP
response to nicorandil decreased immediately after
cardioversion but recovered after one week. These
data suggest that electrical remodeling in patients
with persistent AF is mediated by the IKATP channel
and that this diﬀerence resolved after patients were
maintained in normal sinus rhythm for a period of
one week.
Further, the WL was shorter immediately after
cardioversion when compared to seven days after
cardioversion or to patients in normal sinus rhythm.
Further, nicorandil administration resulted in an
increase in WL. Because WL is a major determinant
of the vulnerability to developing and maintaining
AF, these data suggest that nicorandil may prevent
the recurrence of AF after cardioversion.
Atrial Refractoriness
Other studies have demonstrated that rapid depo-
larizations result in increased cytosolic Ca2þ con-
centration (calcium overload) and ERP shortening in
cardiac myocytes4,16–19) via changes in ICaL, ITo and
INa and that inhibition of INa results in decreased
conduction velocity. Further, Balana et al. reported
that chronic AF was associated with down-regulated
IKATP currents,
8) and Brundel et al. reported that
mRNA levels of Kir6.2, which encodes for a portion
of the IKATP protein, are reduced in patients with
Figure 3 Conduction velocity; time course
and eﬀect of nicorandil.
Conduction velocity was calculated as acti-
vation time divided by distance from the
distal bipole3–4 to the proximal bipole7–8 at
each spline of a basket catheter.
Figure 4 Wavelength; time course and
eﬀect of nicorandil.
Wavelength was shorter following cardiover-
sion in comparison to wavelength in control
subjects. Further, wavelength was longer on
day 7 than just following cardioversion (day
1). Nicorandil administration resulted in
prolongation of wavelength at both (Day 1
and Day 7) time points.
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persistent AF.7) They also demonstrated that the
reduction in levels of Kv4.3, Kv1.5 and Kv3.1,
which encode for portions of the ITo, IKur and IKAch
proteins, could be reversed by maintenance of sinus
rhythm.
One study reported that atrial blood ﬂow increases
2- to 3-fold within 5 seconds after initiation of atrial
ﬁbrillation,20) but others have reported that rapid
atrial rates result in reduced atrial blood ﬂow after
six weeks in a pacing model.21) Since oxygen
consumption increases with rapid atrial excitation,
rapid atrial rates likely result in myocardial hypoxia,
which is consistent with reports of decreased intra-
cellular creatinine phosphate levels in the context of
atrial ﬁbrillation.22) This energy depletion may lead
to a decrease in the intracellular ATP concentration
and subsequent activation of IKATP channels, thereby
shortening APD, suppressing inward calcium current
during excitation, and preventing atrial cell calcium
overload.
The present study demonstrated that ERP was
shortened in the context of AF but normalized after
one week of normal sinus rhythm, which is con-
sistent with published reports of ERP shortening and
its time course by electrical remodeling after atrial
ﬁbrillation.23) Further, the present study demonstrat-
ed that nicorandil administration did not aﬀect ERP
immediately after cardioversion but did shorten ERP
at the 7-day time point. This change in the response
to nicorandil may occur via a decrease in IKATP
channel gene expression that subsequently leads to a
reduction in the current density of IKATP. Alterna-
tively, it is possible that the IKATP channels were
already activated by relative ischemia, which would
limit any further increase in response to nicorandil.
Conduction Velocity and Wavelength
The WL is deﬁned as the distance traveled by the
depolarization wave and can be determined by
multiplying the CV by the ERP. A shortened
wavelength in the atrium results in increased
vulnerability to development and maintenance of
AF. Sodium channel blockers (class I anti arrhyth-
mic drugs) prolong the refractory period and de-
crease conduction velocity, thereby counteracting
the change in WL and promoting conversion to
normal sinus rhythm. L-type calcium channel block-
ers, such as verapamil, decrease intracellular Ca
overload18) and electrical remodeling but also short-
en the refractory period and decrease conduction
velocity. Thus, verapamil may prevent electrical
remodeling but not AF recurrence.
Any increase in the IKATP current shortens the
APD, which subsequently limits calcium entry
during excitation and prevents calcium overload.
Furthermore, the IKATP current repolarizes the
resting potential, thereby increasing the sodium
current and conduction velocity. These eﬀects of
the IKATP channel oppose the eﬀects of shortened
wavelength.
Clinical implication
The present study demonstrated that nicorandil
shortens ERP, increases conduction velocity, and
prolongs the wavelength. These data suggest that
nicorandil may be useful in preventing the recur-
rence of AF following cardioversion.
Limitations
Because of the methodological risk inherent in the
trans-septal approach, the present study conducted
EPS measurements in the right atrium alone. This
may be insuﬃcient, as recent studies reported that
AF is propagated mainly from the pulmonary vein
and left atrium. Further, physical limitations pre-
vented contact of all the splines of the basket
catheter to the right atrial wall, which prevented
optimal assessment of EPS parameters.
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